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Introduction
Neonatal sepsis is an important but underestimated problem 
around the world. It is defined as disease affecting newborns ≤ 1 month 
of age with clinical symptoms and positive blood cultures. Infection 
is an important cause of morbidity and mortality during the neonatal 
period, despite the great improvements in intensive neonatal care and 
the use of extended spectrum antimicrobial agents. The incidence of 
this disease in developed countries is 1/1,000 in normal term neonates 
and 4/1,000 in preterm neonates. These values increase in low-weight 
preterm neonates [1]. In developing countries, this incidence increases 
to 2.2-8.6/1,000 live births [2]. Neonatal sepsis can be subdivided into 
early-onset neonatal sepsis and late-onset neonatal sepsis. 
Early Onset Neonatal Sepsis 
EONS can be acquired vertically from the pregnant woman before 
or during delivery. In this case, microorganisms present in the genital 
tract of the mothers are of great importance [3]. The symptoms appear 
within the 72 hours of life. EONS is a serious problem among very-
low-birth-weight (VLBW) neonates and is associated with at least a 
three-fold increased risk of mortality [4]. The estimated incidence in 
this group is about 15-19/1000 live births [5].
Among the risk factors associated with EONS, the duration of 
gestation at delivery and the presence of maternal genital tract infection 
are the most common. In the case of early neonatal sepsis caused 
by bacteria, these microorganisms could arise from a prematurely 
ruptured amniotic membrane which becomes infected generally 
affecting the amniotic fluid or preterm delivery in a mother colonized 
by such bacteria and who may have a much higher risk of infecting 
their offspring due to the immaturity of their immune system [6,7]. 
The intraamniotic infection can affect maternal tissues such as decidua 
and myometrium, and also fetal tissues such as amniotic and chorionic 
membranes (chorioamnionitis), amniotic liquid (amnionitis), umbilical 
cord (funisitis) and placenta (vilitis) [8]. The microorganisms can arrive 
to the amniotic cavity through the blood system of the placenta, by 
invasive procedures during gestation (amniocentesis, etc) and by an 
ascending pathway [9]. 
Ascending infection from the genital tract of the mother to the fetus 
requires the following steps [9]:
I- Presence of bacteria in the vagina/cervix.
II- Bacteria residing in the decidua.
III- The bacteria might colonize the amnion or the chorion, going
through the fetal vessels or crossing the amnion, reaching the amniotic 
cavity. 
IV- The bacteria enter the fetus through contact with the infected
amniotic liquid and reach the blood, causing sepsis.
Intrauterine or congenital transmission through the placenta 
affecting the fetus during pregnancy should be differentiated from 
perinatal transmission, which takes place at delivery and is caused by 
contact with the microbiota of the birth canal and perineal area.
The main vertically transmitted microorganisms causing EONS 
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are Streptococcus agalactiae (or group B Streptoccocus GBS) and 
Escherichia coli, followed by Coagulase-negative Staphylococcus 
(CONS), Haemophylus influenza and Listeria monocytogenes [3]. These 
microorganisms are an important source of problems for the health of 
neonates worldwide. 
Several studies have corroborated this etiological data. Stoll et al. 
[10] found that 44% and 10.7% of EONS were caused by E. coli and SGB, 
respectively. Among EONS cases Vergnano et al. [11] reported that
50% were caused by SGB and 18% by E. coli, this last microorganism
being more frequent among very low birth-weight (VLBW) neonates.
Other studies are compiled in Table 1 [12-18].
Dagnew et al. [19] carried out a review of the studies about 
the frequency of GBS causing EONS in developing countries. The 
incidence rate of 0-2.06 per 1,000 live births and the prevalence of other 
microorganisms causing EONS varied within and between geographic 
regions. In Arabic countries, Gram-negative microorganisms are more 
frequently found as cause of EONS than Gram-positive microorganisms 
[20]. Finally, Klebsiella spp. (from blood samples) and Staphylococcus 
aureus (from pus swabs samples) were the bacteria more frequently 
involved in EONS in Tanzania [21].
Late Onset Neonatal Sepsis 
LONS occurs at 4-90 days of life and is acquired from the care 
giving environment [22]. The incidence ranges from 1.87 to 5.42 per 
1,000 live births [11]. The microorganisms most frequently found 
to cause LONS are CONS, Staphylococcus aureus, E. coli, Klebsiella, 
Reference Geographical area Period GBS E.coli
Brzarro et aL (2005) 
[12] Yale (USA) 1989-2003 49% 24%
Coben-Wolanarez et 
al. (2009) [13] USA 1996-2007 1.01/1,000 0.65/1,000
Van den hoggen et 
al. (2010)[14] Netherlands 2003-2006 0.7% 0.2%
Vergnano et al. 
(2011)[15] England 2006-2008 50% 18%
Sgro et al. (2011) 
[16] Canada 2006-2008 163% 264%
Stoll et al. (2011)[17] USA 2006-2009 43% 29%
Weston et al. (2011) 
[18] USA 2005-2008 38% 24%
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Pseudomonas, Enterobacter, Candida, GBS, Serratia, Acinetobacter and 
Anaerobes [11, 20, 23]. The main risk factors associated with LONS are 
prematurity, central venous catheterization (duration > 10 days), nasal 
canula, gastrointestinal tract pathology, exposure to antibiotics, and 
prolonged hospitalization [7, 24]. Didier et al. [25] found three major 
types of late onset neonatal infections (LONI): E. coli-induced urinary 
tract infection, CONS septicemia affecting preterm infants and severe 
GBS infections. Other studies are compiled in Table 2.
In spite of the decrease of early-onset GBS sepsis due to the 
implementation of universal screening and intrapartum prophylaxis, 
late-onset GBS sepsis remains unchanged, being an important public 
health problem and associated with a high mortality and morbidity 
in preterm newborns [25]. This observation is in accordance with the 
hypothesis that LONS is usually acquired from the environment. 
Several studies have related antenatal antibiotic treatment to the 
increase of antibiotic-resistant cases of LONS, mainly due to E. coli [25-
28]. 
To prevent nosocomial infections, it is important that good the 
hand hygiene that has been promoted by several global programs is 
carried out. Intravascular catheters and the fragile skin of the neonates 
are important points of entrance for intrahospital microorganisms with 
the consequent risk of neonatal sepsis [29].
Symptoms and Diagnosis
The clinical symptoms manifested by neonates with EONS and 
LONS are non-specific and usually include temperature instability, 
respiratory problems, apnea, feeding intolerance, etc. [7]. Generally, 
the diagnosis of neonatal sepsis diagnosis is carried out by blood, CSF 
and urine cultures. Nowadays, other diagnostic tools such as complete 
blood cell count, C-reactive protein, procalcitonin, mannose binding 
lectin, cytokine profile, etc. are being studied. In the case of LONS, acute 
phase reactants, chemokines and cytokines, and cell-surface antigens 
are non-specific biomarkers that have been studied for diagnosis and 
management [30]. More recently, the use of genomics and proteomics 
are being analyzed for detecting neonatal sepsis. 
The diagnosis of well-defined neonatal sepsis is difficult due to 
the high number of negative cultures. For this reason, the term of 
clinical sepsis has been created based on the symptoms and clinical 
characteristics presented by the neonate [31]. 
Neonatal Sepsis Treatment
Antimicrobial treatment of neonates with suspected sepsis must 
start immediately after birth and without delay. The isolation and 
antimicrobial susceptibility tests are not immediately available and 
results are not obtained in 24 hours. For these reasons, antimicrobial 
treatment is usually empirical using antibiotics effective against the 
most likely pathogens [32]. The empirical treatment of EONS consists 
of ampicillim (Am) and gentamicin (Gm), which cover common 
pathogens such as GBS, Gram-negative bacteria and Listeria and 
have synergic action. The combination of ampicillim - cefotaxime 
is only given in the case of meningitis determined by CSF positivity 
or by clinical suspicion. In the case of LONS, the therapy must be of 
extended spectrum antibiotics in order to cover Gram-negative and 
Gram-positive microorganisms. The duration of antibiotic therapy is 
of 10 days in EONS without meningitis, 10-14 days in LONS without 
meningitis, and 14-22 days in the cases of neonatal meningitis. However, 
an increase in the percentage of Gram-negative bacteria resistant to Am 
and Gm has been observed [24, 33, 34]. Several studies found that the 
75-78% of E. coli strains causing EONS were ampicillin-resistant and 
19-53% were gentamicin-resistant [24, 33]. In the case of E. coli isolates 
from LONS, between 19-50% were ampicillin-resistant and 9-16% 
were gentamicin-resistant [24, 33]. This trend has also been observed 
in developing countries [35]. For these reasons, although the current 
guidelines for empirical therapy in neonates seem to be appropriate 
[32], it is necessary to carry out studies about the susceptibility of 
bacteria causing neonatal sepsis in order to avoid an emergence and/
or an increase in resistance levels. After empirical treatment, the 
choice of the antibiotics depends on the microorganism isolated, their 
antimicrobial susceptibility and the mechanisms of resistance used by 
the microorganism. 
CDC Prophylaxis Guidelines
Streptococcus agalactiae or group B Streptococcus (GBS) has been 
the main etiologic agent of early neonatal sepsis in developed countries. 
In developing countries, this remains to be confirmed, although the few 
reports available point out that GBS is also a highly prevalent cause of 
neonatal infections. This microorganism belongs to the gastrointestinal 
tract microbiota from where it can colonize the vagina. Colonization of 
a pregnant woman’s vagina is very important, as it implies an enhanced 
risk of GBS being transmitted vertically to the child before or at birth, 
and subsequently causing infection in the newborn. In Spain, it has been 
reported that 10-18.5% of pregnant women are colonized by GBS [36] 
; 22.76% in Tehran [37] ; 6% in Iran [38]; 19% in Poland [39]; and 20% 
in Taiwan [40]. To avoid this enhanced risk of vertical transmission, 
several diagnostic and prophylactic protocols have been proposed. 
In 1996, the Center of Disease Control (CDC) recommended taking 
vaginal and rectal samples from pregnant women in their last antenatal 
visit and administering a prophylactic antibiotic such as penicillin G 
or ampicillin during pregnancy or at the time of delivery in women 
found to be colonized by GBS in antenatal screenings. If the pregnant 
woman is allergic to betalactamics, erythromycin or clindamycin 
must be used [41]. When implemented, the use of these prophylactic 
measures resulted in a decrease in the incidence of infection by GBS. 
A good example of this success was a study carried out in 10 hospitals 
of Barcelona (Spain) in which it was found that the incidence of GBS 
as cause of neonatal sepsis was reduced from 1.92/1.000 newborns in 
1994 to 0.26/1.000 newborns in 2001 (p < 0,001) [42]. Another study 
revealed a decrease in the incidence of GBS vertically transmitted 
Reference Geographical area Period GBS E.coli S. aureus CONS
Bizzaro et al. [12] Yale (USA) 1989-2003 4% 10% 7% 43%
Cohen-Wolkowiez et al. [15] USA 1996-2007 0.24/1,000 0.6/1,000 1.01/1,000 1.22/1,000
Vergnano at al.  [14] England 2006-2008 8% 13% 18% 54%
Waters  et al.  (23] Low & middle income countries 1980-2010 2.4% 12.2% 14.9%
Hammoud et al. (26] Kuwait 2005-2009 0.3% 5.8% 1.7% 35.5%
Didier C et al.  [25] Alasce (France) 2007 7% 56% 12.7% 13.6%
Downie et al.  [27] Developing countries 1993-2009 6% 8% 25% 2%
Table 2: Studies about etiology of LONS
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neonatal sepsis from 65.4% to 36.4% due to the CDC prophylaxis [43]. 
Data reported by the CDC showed that after implementation of the 
guidelines, the incidence of EONS by GBS reduced from 1.7/1000 live 
births in 1993 to 0.34/1000 live births in 2004 [44]. 
With intrapartum prophylaxis, the proportion of women exposed 
to intrapartum antibiotics has doubled [45]. In addition, the incidence 
of bacterial species causing EONS has changed. Several studies have 
associated this change in the etiology of EONS with the implementation 
of GBS prophylaxis. Thus, EONS by GBS has decreased but an increase 
in the rates of other microorganisms has been reported, mainly E. coli 
[1, 46, 47] especially in low-birth weight infants [43].
Nonetheless, not only has a change in the etiology of EONS been 
observed but an increase in Am-resistant bacteria causing EONS 
has also been described [24,33,34]. In the last years, GBS presenting 
reduced penicillin susceptibility (PRGBS) has been reported [48,49]. 
The increase in the levels of penicillin resistance has been attributed 
to amino acid substitutions in the penicillin-binding protein 2X. These 
isolates also presented fluoroquinolone and/or macrolide resistance 
[50,51]. In addition, it is estimated that about the 12.45-48% of GBS 
isolates from EONS were erythromycin-resistant and about the 11.8-
28% were clindamycin-resistant [41, 52,53] being a serious problem for 
empirical prophylaxis. 
Several studies have found a relationship between the increase 
of the administration of intrapartum prophylaxis and the increase of 
EONS by non-group B streptococcal microorganisms that are resistant 
to ampicillin [10,43, 54]. Friedman et al. [24] found an association 
between the emergence of resistant E. coli and PROM, high temperature 
and intrapartum prophylaxis. However, other studies did not find a 
significant change in the incidence of ampicillin-resistant non-group B 
streptococcal microorganisms causing EONS after implementation of 
GBS screening and intrapartum prophylaxis. Lin et al. [37] described 
an incidence of ampicillin-resistant E. coli of about 88.9% in 2004 and 
92.9% in 2008. Schrag et al [1] determined that exposure to intrapartum 
antibiotic therapy did not increase early-onset E. coli infection but it 
was only effective in preventing E. coli infection among term neonates 
(Table 3) [55-57].
Conclusion
Neonatal sepsis remains an important but underestimated problem 
around the world. In spite of intrapartum prophylaxis, epidemiological 
surveillance of other pathogens causing early-onset neonatal sepsis is 
needed. The development of pathogen-specific strategies to prevent 
this infection could be an important diagnostic tool to reduce the cases 
of early-onset neonatal sepsis. In addition, studies on antimicrobial 
resistance of the microorganisms causing neonatal sepsis are needed 
in order to improve empirical treatment and avoid the emergence of 
resistances.
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